Bakhu Holdings Reports Increased Net Losses and Operational Challenges for January 2025

Bakhu Holdings, Corp. has reported its financial results for the three and six months ended January 31, 2025, revealing a continued lack of revenue generation and an increase in net losses. The company reported a net loss of $600,468 for the three months ended January 31, 2025, compared to a loss of $120,680 for the same period in 2024. For the six months, the net loss was $1,371,855, up from $1,252,158 in the prior year. The company has not generated any revenue during these periods, maintaining a cumulative loss of $52,283,012 since its inception.

Operating expenses for the three months increased to $490,976 from $367,230 year-over-year, primarily driven by higher consulting fees, which rose to $324,237 from $171,254. For the six months, total operating expenses decreased to $1,154,416 from $1,434,597, reflecting a reduction in professional fees and other operating expenses. The company also recorded net other expenses of $109,492 for the three months ended January 31, 2025, compared to net other income of $246,550 in the previous year, largely due to a lack of gains from debt settlements that had previously bolstered income.

In terms of strategic developments, Bakhu Holdings has faced significant operational challenges, including the abandonment of its laboratory facility and the disposal of related equipment due to a default on a settlement agreement with VO Leasing Corp. This has halted the company's efforts to commercialize its licensed technology for cannabis production. Following a leadership crisis that resulted in the resignation of all officers and directors in January 2025, the company has since appointed new management in March 2026, aiming to stabilize operations and address its financial obligations.

As of January 31, 2025, Bakhu Holdings reported total liabilities of $11,570,184, with current liabilities amounting to $3,289,129. The company has no cash and cash equivalents, reflecting a decrease of $25,461 from the previous period. The management has indicated that it will require approximately $8.5 million in external capital over the next 12 months to fund its activities, including reestablishing laboratory work and covering operational costs. The company’s ability to continue as a going concern is contingent upon securing this funding and successfully executing its business plan.

Looking ahead, Bakhu Holdings has expressed uncertainty regarding its revenue generation timeline, emphasizing the need for further capital raising activities to resume its commercialization efforts. The company plans to seek joint ventures and partnerships to leverage its licensed technology, but it acknowledges that its current lack of revenue and market presence poses significant challenges to attracting necessary financing.